Preliminary experiments did not show a significant effect of any of these compounds on CEBPD expression in pancreatic adenocarcinoma cells and further studies are needed to find potent upstream regulators of C/EBP δ in this context. The gene discussed is CEBPD; the disease is pancreatic adenocarcinoma.